Buy Gujarat Themis Biosyn, target price Rs 909: HDFC Securities
Gujarat Themis Biosyn Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap for the year ending 31-Mar-2022.

Gujarat Themis Biosyn Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 63.05 Crore) operating in Pharmaceuticals sector.
Gujarat Themis Biosyn Ltd. key Products/Revenue Segments include Pharmaceuticals, Scrap for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company reported a Standalone Total Income of Rs 49.09 Crore, up 5.87 % from last quarter Total Income of Rs 46.37 Crore and up 37.26 % from last year same quarter Total Income of Rs 35.76 Crore. Company reported net profit after tax of Rs 18.70 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 74.99 per cent stake in the company as of 30-Sep-2022, while FIIs owned 0 per cent, DIIs 0.02 per cent.
Download ET Markets APP